Does MEPOLIZUMAB Cause Chronic obstructive pulmonary disease? 1,107 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,107 reports of Chronic obstructive pulmonary disease have been filed in association with MEPOLIZUMAB (Nucala). This represents 2.6% of all adverse event reports for MEPOLIZUMAB.
1,107
Reports of Chronic obstructive pulmonary disease with MEPOLIZUMAB
2.6%
of all MEPOLIZUMAB reports
51
Deaths
773
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From MEPOLIZUMAB?
Of the 1,107 reports, 51 (4.6%) resulted in death, 773 (69.8%) required hospitalization, and 24 (2.2%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
Yes, Chronic obstructive pulmonary disease is listed as a known adverse reaction in the official FDA drug label for MEPOLIZUMAB.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
OMALIZUMAB (724)
Which MEPOLIZUMAB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE